CELLULAR IMMUNITY ACTIVATION METHOD BY STIMULATING RD1 COMPLEX PROTEINS AS VIRULENCE MARKER ON Mycobacterium tuberculum TO ESTABLISH DIAGNOSIS ON TUBERCULOSIS AND LATENT TUBERCULOSIS INFECTION
Downloads
Corbett, E.L., Watt, C.J., et al., 2003. The growing burden of tuberculosis:global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163 (9), 1009–1021.
World Health Organization. Global tuberculosis report. Available at, http://www.who.int/tb/publications/global_report/gtbr12_executivesummary.pdf;2012 [accessed on 30.04.13].
Departemen Kesehatan RI. Riset Kesehatan Dasar 2007. Jakarta: 2008
Raja A. 2004. Immunology of Tuberculosis. Indian J Med Res; 120 : 213 – 232.
Rosas-Taraco, A.e.a., 2006. Mycobacterium tuberculosis upregulates coreceptors CCR5 and CXCR4 while HIV modulates CD14 favoring concurrent infection. AIDS Res Hum Retroviruses, 22, pp.45-51
Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. JAMA 1999;282: 677e86.
Marais BJ, Ayles H, Graham SM, and Godfrey-Faussett P, “Screening and preventive therapy for tuberculosis,” Clinics in Chest Medicine, vol. 30, no. 4, pp. 827–846, 2009
Richeldi, L., 2006. An update on the diagnosis of tuberculosis infection. Am. J. Respir. Crit. CareMed. 174 (7), 736–742
Huebner, R.E., Schein, M.F., et al., 1993. The tuberculin skin test. Clin. Infect. Dis. 17 (6), 968–975
Alcaide F and Coll P. 2011. Advances in Rapid Diagnosis of Tuberculosis Disease and Anti tuberculosis drug resistance. Enferem Infecc Microbiol. Clin. 29 (supl 1):34-40
Dayal R, Singh A, Katoch VM, Joshi B, Chauhan DS, Singh P, Kumar G, Sharma VD. Serological diagnosis of tuberculosis. Indian J PEdiatr 2008;75:1219-21
American Thoracic Society. 2000. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 161 (4 Pt 2), S221-247.
Pai, M., Minion, J., et al., 2010. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr. Opin. PulmMed. 16 (3), 271–284
Raja A, Ranganathan UD, BEthunaickan R. 2006. Improved diagnosis of pulmonary tuberculosis by detection of antibodies against multiple Mycobacterium tuberculosis antigens. Diagn Microbiol Infect Dis; 60 : 361 – 8.
Brock, I., Munk, M.E., et al., 2001. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int. J. Tuberc. Lung Dis. 5 (5), 462–467.
Renshaw PS, Lightbody KL, Veverka V, Muskett FW, Kelly G, Frenkiel TA, Gordon SV, Hewinson RG, Burke B, Norman J, Williamson RA, Carr MD. Structure and function of the complex formed by tuberculosis virulence factors CFP-10 and ESAT-6. EMBO J 200;24:2491-8
Kumar G, Shankar H, Chahar M, Sharma P, Yadav VS, Chauhan DS, Katoch VM, Joshi B. 2012. Whole cell & culture filtrate proteins from prevalent genotypes of Mycobacterium tuberculosis provoke better antibody & T cell response than laboratory strain H37Rv. Indian J Med Res 135, pp745-755.
Muttucumaru DGN and Parish T. 2004. The Molecular Biology of Recombination in Mycobacteria: What Do We Know and How Can We Use It. J. Horizon Scientific Press. Curr. Issues Mol. Biol. 6:145-158.
Brodin P, Rosenkrands I, Andersen P, Cole ST, Brosch R. 2004. ESAT-6 proteins : protective antigens and virulence factors? Trends Microbiol 53:1677-93.
Bruiners, N. 2012. Investigating the Human- Mycobacterium . tuberculosis interactome to identify the host targets of ESAT-6 and other mycobacterial antigens, (December).
Daugelat S, Kowall JMattow J, Bumann D, Winter R, Hurwitz R, and Kaufmann S.H. 2003. The RD1 proteins of Mycobacterium tuberculosis: expression in Mycobacterium smegmatis and biochemical characterization. Microbes Infect Vol 5(12) pp:1082-95.
Lightbody KL,Ilghari D, Waters LC, Carey G, Cailey MA, Wiliamson RA, Renshaw PS, Carr MD. Molecular features governing the stability and specificity of functional complex formation by Mycobacterium tuberculosis CFP-10/ESAT-6 family proteins. J Biol Chem 2008;283:17681-90
Xu, J., O. Laine, M. Masciocchi, J. Manoranjan, J. Smith, S.J. Du, N. Edwards, X. Zhu, C. Fenselau, nad L.Y. Gao. (2007). A unique Mycobacterium ESX-1 protein co-secretes with CFP-10/ESAT-6 and is necessary for inhibiting phagosome maturation. Mol. Microbiol. 66.pp: 787-800
Triasih R, Rutherford M, Lestari T, Utarini A, Robertson CF, Graham SM. Contact Investigation of Children Exposed to Tuberculosis in South East Asia: A Systematic Review. Journal of Tropical Medicine. 2012:1-6
Van Rie A, Beyers N, Gie RP, Kunneke M, Zietsman L, and Donald PR, “Childhood tuberculosis in an urban population in South Africa: burden and risk factor,” Archives of Disease in Childhood, vol. 80, no. 5, pp. 433–437, 1999
World Health Organization, Guidance for National Tuberculosis Program on the Management of Tuberculosis in Children, WHO, Geneva, Switzerland, 2006
Lighter J. Rigaud M. Diagnosis childhood tuberculosis: traditional and innovative modalities. Curr Probl Pediatr Adolesc Health Care 2009; 39: 61-68
Marais BJ, Gie RP, Schaaf HS et al., “The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era,” International Journal of Tuberculosis and Lung Disease, vol. 8, no. 4, pp. 392–402, 2004
Brooks GF, Carroll KC, Butel JS, Morse SA, Mietzner TA. 2010. Jawetz, Melnick & Adelberg’s Medical Microbiology. 25th edition. McGraw Lange.
Chul Su Yang, Jae Min Yuk, Eun Kyong Jo. 2009. Immune Netw 9(2) : 46 – 52.
Meena LS, Rajni. 2010. Survival mechanisms of pathogenic Mycobacterium tuberculosis H37Rv, the FEBS Journal 277:2416-2427.
Buchmeier N. Blanc-Potard A, Ehrt S., Piddington D. Reley L and Groisman EA.2000. A parallel intraphagosomal survival strategy shared by Mycobacterium tuberculosis and Salmonella enteric J. molecular Microbiology (2000) 35(6), 1375-1382.
Styblo K. Recent advances in epidemiological research in tuberculosis. Adv Tuberc Res 1980;20:1e63.
Gordon AH, Hart PD, Young MR. Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature 1980; 286 : 79 – 81.
Hart PD, Armstrong JA, Brown CA, Draper P. Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria. Infect Immun 1972; 5 : 803-7.
Anandaiah A, Sinha S, Bole M, Sharma SK, Kumar N, Luthra K, Xin Li, Xiuqin Zhou, Nelson B, Xinbing Han, Tachado SB, Patel NR, Koziel H. 2013. Vitamin D Rescues Impaired Mycobacterium tuberculosis-Mediated Tumor Necrosis Factor Release in Macrophages of HIV-Seropositive Individuals through an Enhanced Toll-Like Receptor Signalling Pathway In Vitro. Infection and Immunity 81 no 1 : 2-10.
Jinhee Lee, Michele Hartman, Hardy Kornfeld. 2009. Macrophage apoptosis in Tuberculosis. Yonsei Med J 50(1) : 1-11.
Majlessi I, Brodin P, Brosch R, Rojash MJ, Khun H, Huerre M, Cole ST, Leclerc C. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. J Immunol 2005;174:3570-9
The Indonesian Journal of Tropical and Infectious Disease (IJTID) is a scientific peer-reviewed journal freely available to be accessed, downloaded, and used for research. All articles published in the IJTID are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which is under the following terms:
Attribution — You must give appropriate credit, link to the license, and indicate if changes were made. You may do so reasonably, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
